Asbestos and Health
There is a growing amount of research which indicates that asbestos exposure can lead to both physical and genetic changes in the body that result in a number of different health problems and diseases .Common health issues that may signal the presence of asbestos-induced cancer include: extreme fatigue, pain at the tumor site, shortness of breath and persistent coughing, fluid buildup, and even bowel obstruction. Each of these types of symptoms can gradually become debilitating.
Asbestos exposure has been more directly linked to the development of asbestosis, lung cancer, and mesothelioma . Asbestosis is a condition in which inflammation in the lungs causes coughing, shortness of breath, and the scarring of lung tissue which makes it difficult to breathe. This condition progresses very slowly (over 10 to 20 years) and is not a form of cancer, but the scarring that occurs makes it difficult for the lungs to properly transport carbon dioxide and oxygen. Lung cancer directly affects the actual lungs, while mesothelioma affects the protective lining in the lungs, heart, abdomen, and rarely the testes.
Additional lung problems that are caused by asbestos exposure include the development of pleural plaques in the lining of the lungs, a thickening of the membranes that protect the lungs, and fluid buildup between the inner walls of the chest and the lungs .
Individuals who have been exposed to asbestos also have a high risk of developing autoimmune diseases (e.g., rheumatoid arthritis, sclerosis) . Furthermore, evidence has started to indicate that asbestos may enter the circulation where it may be able to affect addition regions in the body such as the brain, throat, voice box, bladder, kidneys, gallbladder, and the gastrointestinal tract, among others .
If you or someone you know has been exposed to asbestos, has asbestos-induced mesothelioma, or suffers from lung problems due to exposure contact us for legal advice regarding possible financial compensation.
- Huang SX, Jaurand MC, Kamp DW, Whysner J, Hei, TK (2011). Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases.J Toxicol Environ Health B Crit Rev,14(1-4):179-245. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118525/
- Tekath M, Dutheil F, Bellini R, Roche A, Pereira B, Naughton G, Chamoux A, Michel JL. (2014). Comparison of the ultra-low-dose Veo algorithm with the gold standard filtered back projection for detecting pulmonary asbestos-related conditions: a clinical observational study.BMJ Open,4(5):e004980. Retrieved from http://bmjopen.bmj.com/content/4/5/e004980.long
- Bunderson-Schelvan M, Pfau JC, Crouch R, Holian A. (2011). Nonpulmonary outcomes of asbestos exposure. J Toxicol Environ Health B Crit Rev. 14(1-4):122-152. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118539/